Trivascular Lands $60,000,000 Series D Funding Round

  • Feed Type
  • Date
    6/5/2012
  • Company Name
    Trivascular
  • Mailing Address
    3910 Brickway Blvd Santa Rosa, CA 95403
  • Company Description
    Trivascular is developing novel endovascular repair devices to treat abdominal aortic aneurysms (AAA).
  • Website
    http://www.trivascular2.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $60,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds from the financing will be used to pursue U.S. PMA approval of the Ovation Abdominal Stent Graft System, drive further sales expansion internationally, fuel product development efforts and initiate U.S. commercial activity.
  • M&A Terms
  • Venture Investor
    Kaiser Permanente Ventures
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Redmile Group
  • Venture Investor
    Delphi Ventures
  • Venture Investor
    MPM Capital
  • Venture Investor
    Kearny Venture Partners
  • Venture Investor
    Pinnacle Ventures

By posting a comment, you agree to our terms and conditions.